iNanoBio
AZ - ScottsdaleBiotechnology
Focus: 3D nanopore – transistor device for sequencing the whole human genome with high accuracy
iNanoBio is a life sciences company focused on 3D nanopore – transistor device for sequencing the whole human genome with high accuracy.
Profile data last refreshed Yesterday
Open Jobs
0
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Sampling
COVID-19Clinical Trials (1)
NCT04465981Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients
N/AHelp build intelligence for iNanoBio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.